Back to Screener

Healthcare

Health Catalyst, Inc.(HCAT)

Live Price

Offline

$1.74

-1.69% today

Window Change

+24.64%

Window

May 29, 2026 โ†’ Jun 22, 2026

Market Cap
$90.00M
Revenue Growth
+1.5%
EPS Growth
-121.7%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 16 bars ยท May 29, 2026 โ†’ Jun 22, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Health Catalyst, Inc. (HCAT) is a Healthcare stock with a market cap of $90.00M and listed on NASDAQ. The stock last traded around $1.74 and up 24.6% across the available one-year price window (May 29, 2026 โ†’ Jun 22, 2026). Baseline metrics include revenue growth of +1.5%, EPS growth of -121.7%, a dividend yield of 0.0%. What stands out right now is revenue +1.5%, EPS -121.7%, free cash flow +87.1% with operating margin -11.6% and ROIC -8.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines HCAT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

+1.5% vs +7.6% peer median

Operating Margin

Below sector median

-11.6% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 6, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at +1.5% and EPS is at -121.7%, with operating margin around -11.6%.

Benchmark Edge

HCAT vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

HCAT

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

HCAT Max Drawdown

-17.53%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for HCAT and SPY.

Calendar-year return history is still loading or unavailable.
Health Catalyst, Inc. logo

Company Overview

Health Catalyst, Inc.

NASDAQ Global Select

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

Leadership
Benjamin Albert
IPO Date
Jul 25, 2019
Employees
1.5k
Street Address
10897 South River Front Parkway
Mailing
South Jordan, UT, 84095
Region
South Jordan, UT, US
Reporting Currency
USD
Investor Line
801 708 6800
Last Updated
Apr 29, 2026
CIK: 0001636422ISIN: US42225T1079CUSIP: 42225T107
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
14.8
Price/Sales
0.3
Price/Book
0.4

Growth

Revenue
+1.5%
EPS
-121.7%
Free Cash Flow
+87.1%

Profitability

Gross Margin
33.5%
Operating Margin
-11.6%
Net Margin
-57.2%
ROE
-54.7%
ROIC
-8.6%

Balance Sheet

Debt/Equity
0.70
Current Ratio
1.89

Earnings Reports

๐Ÿ“… Last reportedMay 6, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 6, 26
โ€”
Est 0.01
โ€”
โ€”
Est 69168.9B
โ€”
โ€”
Mar 12, 26
โœ—
0.08
Est 0.09
-11.1%
74679.0B
Est 73967.5B
+1.0%
โ€”
Nov 10, 25
โœ“
0.06
Est 0.05
+20.0%
76323.0B
Est 74076.5B
+3.0%
โ€”
Aug 7, 25
โœ“
0.04
Est 0.03
+33.3%
80721.0B
Est 85136.5B
-5.2%
โ€”
May 7, 25
โ€”
0.01
Est 0.01
0.0%
79413.0B
Est 79161.5B
+0.3%
โ€”
Feb 26, 25
โœ—
0.04
Est 0.11
-63.6%
79606.0B
Est 79592.7B
+0.0%
โ€”
Nov 6, 24
โœ—
0.07
Est 0.10
-30.0%
76353.0B
Est 80684.4B
-5.4%
โ€”
Aug 7, 24
โœ“
0.12
Est 0.09
+33.3%
75902.0B
Est 75000.0B
+1.2%
โ€”
May 9, 24
โœ“
0.05
Est 0.03
+79.0%
74723.0B
Est 74800.0B
-0.1%
โ€”
Feb 22, 24
โœ“
0.02
Est 0.00
+2716.9%
75084.0B
Est 73600.0B
+2.0%
โ€”
Nov 2, 23
โœ“
0.03
Est 0.01
+275.5%
73773.0B
Est 73360.0B
+0.6%
โ€”
Aug 8, 23
โœ“
0.05
Est 0.00
+1448.0%
73213.0B
Est 72630.0B
+0.8%
โ€”
May 9, 23
โœ“
0.05
Est 0.02
+222.8%
73868.0B
Est 71240.0B
+3.7%
โ€”
Feb 28, 23
โœ“
-0.05
Est -0.10
+50.0%
69162.0B
Est 68259.6B
+1.3%
โ€”
Nov 8, 22
โœ“
-0.13
Est -0.20
+35.0%
68354.0B
Est 66817.0B
+2.3%
โ€”
Aug 4, 22
โœ“
-0.03
Est -0.11
+72.7%
70633.0B
Est 69876.8B
+1.1%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.